企業プロフィール

Abeona Therapeutics 株価・ニュース・カタリスト

ティッカー:: ABEO
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

5.94 USD (-0.75%)

終値

最終更新: 2026年8月17日

324M USD

時価総額

株価変動の要因

As of Aug 17, 2026, ABEO closed down 0.75% at $5.94. No new same-company headline was identified in the current news window.

企業概要

Cell and Gene Therapy Company

Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.

ZEVASKYN

ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform.

ABO-701

ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.